Troels Jordansen Appointed as Chief Executive Officer of Yaqrit, Replacing Professor Rajiv Jalan
Position
Chief Executive Officer
Company
Yaqrit
LondonBiotechnologyHealth CareTherapeuticsDescription
Yaqrit, a late-stage biotech and medtech company, announced the appointment of Troels Jordansen as its new Chief Executive Officer. Mr. Jordansen replaces Professor Rajiv Jalan, the company’s Founder and Interim CEO, and is poised to lead the company in several late-stage trials of its products for the treatment of complications associated with advanced liver disease, and to launch a phase 3 study.
Quick answer
Troels Jordansen Appointed as Chief Executive Officer of Yaqrit, Replacing Professor Rajiv Jalan (January 10, 2025). Yaqrit is based in London, England, United Kingdom.
- Who is the new Chief Executive Officer at Yaqrit?
- Yaqrit named Troels Jordansen Chief Executive Officer, announced January 10, 2025.
- What did Yaqrit announce on January 10, 2025?
- Yaqrit, a late-stage biotech and medtech company, announced the appointment of Troels Jordansen as its new Chief Executive Officer. Mr. Jordansen replaces Professor Rajiv Jalan, the company’s Founder and Interim CEO, and is poised to lead the company in several late-stage trials of its products for the treatment of complications associated with advanced liver disease, and to launch a phase 3 study.
- What does Yaqrit do?
- Yaqrit is a clinical-stage company discovering and developing innovative treatments for patients with advanced liver disease at high risk of hospitalization and death.
- Where is Yaqrit based?
- Yaqrit is based in London, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Pulse Biosciences, Inc. (January 10, 2025), Gain Therapeutics (January 10, 2025), Nimbus Therapeutics (January 9, 2025) and MitoRx Therapeutics (January 9, 2025) also announced leadership changes within 45 days of Yaqrit.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pulse Biosciences Appoints Paul A. LaViolette as Chief Executive Officer (January 10, 2025)
- Gain Therapeutics Appoints Gene Mack as President and Chief Executive Officer, Gianluca Fuggetta as Senior Vice President of Finance (January 10, 2025)
- Nimbus Therapeutics appoints Peter J. Tummino, Ph.D. as President of Research and Development (January 9, 2025)
- MitoRx Therapeutics Appoints Dr. Lubor Gaal as Chief Business Officer and Stacey Massey as Finance Director (January 9, 2025)
- GEMMABio Appoints May Orfali, MD, MBA, as Chief Medical Officer (January 9, 2025)
- Noema Pharma Appoints Michael Samar as Chief Financial Officer and Volker Knappertz as Executive Vice President of Research and Development (January 8, 2025)
Who to call at Yaqrit, and when
A new leader at Yaqrit brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Yaqrit raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Yaqrit, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Yaqrit. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Yaqrit changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Yaqrit changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.